Therapeutic Advances in Neurological Disorders

Journal

Overview
Identity

Publication Venue For

A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod. 14. 2021

Disease-modifying therapy prescription patterns in people with multiple sclerosis by age. 14. 2021

Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials. 13. 2020

Clinical trials in multiple sclerosis: potential future trial designs. 12. 2019

Evolution of clinical trials in multiple sclerosis. 12. 2019

Clinical trials in multiple sclerosis: milestones. 11. 2018

Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era. 11. 2018

The effects of deep brain stimulation on sleep in Parkinson’s disease. 4:15-24. 2011

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis. 3:15-28. 2010

International Standard Serial Number (issn)

1756-2856

Electronic International Standard Serial Number (eissn)

1756-2864